Brief: Aprea Therapeutics Announces One-For-Twenty Reverse Stock Split
Feb 13 (Reuters) - Aprea Therapeutics Inc APRE.O :
* APREA THERAPEUTICS ANNOUNCES ONE-FOR-TWENTY REVERSE STOCK
SPLIT
* APREA THERAPEUTICS - COMMON STOCK TO TRADE ON NASDAQ
GLOBAL
SELECT MARKET ON SPLIT-ADJUSTED BASIS FROM FEB 13, UNDER
EXISTING TRADING SYMBOL "APRE"
Source text for Eikon: ID:nGNX53fYP6
Further company coverage: APRE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing